Steward Partners Investment Advisory, LLC Red Hill Biopharma Ltd. Transaction History

Steward Partners Investment Advisory, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	SELL	$0.14 - $695.9 $280 - $1.39 Million	-2,000 Reduced 28.57%	5,000 $0
Q3 2022 Nov 10, 2022	SELL	$0.5 - $523.8 $250 - $261,899	-500 Reduced 6.67%	7,000 $4,000
Q1 2021 May 14, 2021	BUY	$6.98 - $11.29 $17,450 - $28,224	2,500 Added 50.0%	7,500 $54,000
Q4 2020 Feb 11, 2021	BUY	$7.81 - $10.39 $39,050 - $51,950	5,000 New	5,000 $40,000
Q3 2020 Oct 30, 2020	SELL	$6.34 - $10.83 $3,170 - $5,415	-500 Closed	0 $0
Q2 2019 Jul 25, 2019	BUY	$6.34 - $8.8 $3,170 - $4,400	500 New	500 $3,000
Q4 2018 Jan 15, 2019	SELL	$5.18 - $9.35 $2,590 - $4,675	-500 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$6.0 - $11.35 $3,000 - $5,675	500 New	500 $4,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $364M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.